BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 18521717)

  • 1. Erratum: Down-Regulation of the Cyclin-Dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
    Hepatology; 2023 Oct; 78(4):E85. PubMed ID: 37748046
    [No Abstract]   [Full Text] [Related]  

  • 2. Podocytes proliferate: novel mechanism identified in collapsing glomerulopathies.
    Zhu C; Mertens PR
    Int Urol Nephrol; 2013 Feb; 45(1):275-9. PubMed ID: 23136030
    [No Abstract]   [Full Text] [Related]  

  • 3. p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect.
    Kavanagh E; Vlachos P; Emourgeon V; Rodhe J; Joseph B
    Cell Death Dis; 2012 May; 3(5):e311. PubMed ID: 22592318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a).
    Atasoy P; Yilmaz E; Bozdogan O; Ayva S; Batislam E
    Int Urol Nephrol; 2009; 41(1):55-60. PubMed ID: 18521717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study.
    Bozdoğan O; Atasoy P; Batislam E; Başar MM; Başar H
    Tumori; 2008; 94(4):556-62. PubMed ID: 18822693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
    Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
    Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
    Elmore LW; Forsythe R; Forsythe H; Bright AT; Nasim S; Endo K; Holt SE
    Oncol Rep; 2008 Sep; 20(3):613-7. PubMed ID: 18695913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
    Brustmann H
    Int J Gynecol Pathol; 2005 Apr; 24(2):184-92. PubMed ID: 15782075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer statistics, 2007.
    Jemal A; Siegel R; Ward E; Murray T; Xu J; Thun MJ
    CA Cancer J Clin; 2007; 57(1):43-66. PubMed ID: 17237035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in disseminated prostate cancer cells.
    Pfitzenmaier J; Ellis WJ; Arfman EW; Hawley S; McLaughlin PO; Lange PH; Vessella RL
    BJU Int; 2006 Jun; 97(6):1309-13. PubMed ID: 16686730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study.
    Yue H; Jiang HY
    World J Gastroenterol; 2005 Aug; 11(32):5057-60. PubMed ID: 16124066
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.